These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 23020512

  • 1. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
    Khalil A, Zaidman I, Elhasid R, Peretz-Nahum M, Futerman B, Ben-Arush M.
    Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
    [Abstract] [Full Text] [Related]

  • 2. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F, Al-Zahrani H, Mohammed SY, Nassar A, Aljurf M.
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [Abstract] [Full Text] [Related]

  • 3. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
    Großekatthöfer M, Güclü ED, Lawitschka A, Matthes-Martin S, Mann G, Minkov M, Peters C, Seidel MG.
    Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
    [Abstract] [Full Text] [Related]

  • 4. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH, Xu LP, Liu DH, Chen H, Han W, Chen YH, Wang FR, Wang JZ, Wang Y, Zhao T, Chen Y, Fu HX, Liu KY, Huang XJ.
    Clin Transplant; 2013 Aug; 27(1):80-9. PubMed ID: 22938074
    [Abstract] [Full Text] [Related]

  • 5. Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.
    Bieri S, Roosnek E, Ozsahin H, Huguet S, Ansari M, Trombetti A, Helg C, Chapuis B, Miralbell R, Passweg J, Chalandon Y.
    Eur J Haematol; 2011 Aug; 87(2):138-47. PubMed ID: 21535161
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G.
    Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
    [Abstract] [Full Text] [Related]

  • 9. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ, Schuurman R, Visscher H, de Vos M, Bierings M, van Loon AM, Uiterwaal CS, van Baarle D, Sanders EA, Boelens J.
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical features of late onset non-infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation.
    Park M, Koh KN, Kim BE, Im HJ, Seo JJ.
    Clin Transplant; 2011 Jul; 25(2):E168-76. PubMed ID: 21077955
    [Abstract] [Full Text] [Related]

  • 12. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ, Xu LP, Ren HY, Zhang YC, Guo NL, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):766-9. PubMed ID: 12899755
    [Abstract] [Full Text] [Related]

  • 13. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 10; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 14. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA, Vicent MG, Prudencio M, Rodriguez F, Marin C, Serrano A, Sevilla J, Casado J, Madero L.
    Haematologica; 2002 Mar 10; 87(3):292-8. PubMed ID: 11869942
    [Abstract] [Full Text] [Related]

  • 15. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
    Uygun V, Tayfun F, Akcan M, Karasu GT, Kupesiz A, Hazar V, Yeşilipek A.
    Pediatr Hematol Oncol; 2012 Aug 10; 29(5):461-71. PubMed ID: 22712884
    [Abstract] [Full Text] [Related]

  • 16. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH, Chang PM, Li WY, Hsiao LT, Hong YC, Liu CY, Gau JP, Liu JH, Chen PM, Chiou TJ, Tzeng CH.
    Bone Marrow Transplant; 2011 Apr 10; 46(4):567-72. PubMed ID: 20622906
    [Abstract] [Full Text] [Related]

  • 17. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P, Piñana JL, Valcárcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J.
    Biol Blood Marrow Transplant; 2009 Nov 10; 15(11):1439-46. PubMed ID: 19822304
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.